New hope to keep advanced sarcoma at bay after chemotherapy
NCT ID NCT03793361
Summary
This study tested whether a drug called regorafenib could help keep metastatic soft tissue sarcoma from getting worse after initial chemotherapy. It involved 127 adults whose cancer had stabilized or responded to first-line treatment. Patients were randomly assigned to receive either regorafenib or a placebo pill to see which group went longer without their cancer progressing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC SOFT TISSUE SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHRU Besançon
Besançon, 25000, France
-
Centre Antoine Lacassagne
Nice, 06189, France
-
Centre Eugène Marquis
Rennes, 35042, France
-
Centre François Baclesse
Caen, 14076, France
-
Centre Georges-François LECLERC
Dijon, 21079, France
-
Centre Henri Becquerel
Rouen, 76038, France
-
Centre Léon Bérard
Lyon, 69373, France
-
Centre Oscar Lambret
Lille, 59020, France
-
Centre René Gauducheau
Nantes, 44805, France
-
Chu Poitiers
Poitiers, 86000, France
-
Hôpital La Timone
Marseille, 13005, France
-
Hôpitaux universitaires de Strasbourg
Strasbourg, 67000, France
-
Institut Bergonié
Bordeaux, 33076, France
-
Institut Claudius Regaud
Toulouse, 31059, France
-
Institut Curie
Paris, 75005, France
-
Institut Godinot
Reims, 51100, France
-
Institut Gustave Roussy
Villejuif, 94805, France
-
Institut Paoli-Calmettes
Marseille, 13273, France
-
Institut de Cancérologie Lucien Neuwirth
Saint-Priest-en-Jarez, 42270, France
-
Institut régional du Cancer de Montpellier
Montpellier, 34298, France
Conditions
Explore the condition pages connected to this study.